Biomedical Innovations to Combat COVID-19
Editat de Sergio Rosales-Mendoza, Mauricio Comas-García, Omar González-Ortegaen Limba Engleză Paperback – 18 oct 2021
This book is split into four sections: introduction, presenting basic virologic and epidemiological aspects of COVID-19; vaccines against COVID-19, discussing their different types and applications used to develop them; diagnostic approaches for SARS-CoV-2, encompassing advanced sensing and microfluidic-based biosensors; and drug development and delivery, where antivirals based on nanomaterials or drugs are presented.
It is a valuable source for virologists, biotechnologists, and members of biomedical field interested in learning more about how novel technologies can be applied to fasten the eradication of the COVID-19 and similar pandemics.
- Presents updated literature coverage summarizing the most relevant information on COVID-19
- Written by experts from diverse scientific domains in order to provide readers with a thorough view on the subject
- Encompasses tables, figures and information trees especially developed for the book in order to condense and highlight key points for quick reference
Preț: 785.25 lei
Preț vechi: 826.58 lei
-5% Nou
Puncte Express: 1178
Preț estimativ în valută:
150.32€ • 163.76$ • 126.11£
150.32€ • 163.76$ • 126.11£
Carte tipărită la comandă
Livrare economică 11-25 decembrie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780323902489
ISBN-10: 0323902480
Pagini: 410
Ilustrații: 60 illustrations (30 in full color)
Dimensiuni: 216 x 276 mm
Editura: ELSEVIER SCIENCE
ISBN-10: 0323902480
Pagini: 410
Ilustrații: 60 illustrations (30 in full color)
Dimensiuni: 216 x 276 mm
Editura: ELSEVIER SCIENCE
Cuprins
1. Basic virological aspects of SARS-CoV-22. Fundamental aspects of the structural biology of Coronaviruses3. Introduction to the SARS-CoV-2/COVID-19 epidemiology4. Structural biology of the SARS-Cov 2 replisome: evolutionary and therapeutic implications5. Clinical progression of patients with COVID-19: The impact of the pandemic in Latin America6. Overview of the immune response against SARS-CoV-27. Viral-vectored vaccines against SARS-CoV-28. RNA-based vaccines against SARS-CoV-29. Particulate vaccines against SARS-CoV-210. VLPs-based vaccines against SARS-CoV-211. Innovative recombinant protein-based vaccines against SARS-CoV-212. SARS-CoV-2 Vaccines: Current Trends and Prospects of Developing Plant-Derived Vaccines13. Nanobodiestargeting SARS-CoV-214. 2D materials and van der Waals heterostructures platforms for advanced sensing of COVID-1915. Microfluidic-based biosensor for SARS-CoV-2 antibodies16. Antivirals based on nanomaterials against SARS-CoV-217. The potential of drug delivery nanosystems to treat COVID-1918. The role of traditional medicine in the fight against SARS-CoV-2